Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01369758 · ClinicalTrials.gov registry record · NA
MyoSure Hysteroscopic Tissue Removal System Registry Study
A NA study, sponsored by Hologic.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
NCT01369758 is a NA study that has completed, run by Hologic. The registered enrollment target is 290 participants.
The verdict
NCT01369758, a NA study, has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the safety and effectiveness of community gynecologist initiated treatment of intra-uterine polyps and submucosal fibroids with the MyoSure Hysteroscopic Tissue Removal System in a significantly sized patient population.
Interventions
- DEVICE MyoSure Tissue Removal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01369758
The ClinicalTrials.gov registry entry for NCT01369758 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MyoSure Tissue Removal System is the first listed.
NCT01369758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01369758 about?
NCT01369758 is a clinical study titled "MyoSure Hysteroscopic Tissue Removal System Registry Study". The objective of this study is to demonstrate the safety and effectiveness of community gynecologist initiated treatment of intra-uterine polyps and submucosal fibroids with the MyoSure Hysteroscopic Tissue Removal System in a significantly sized patient population.
What is the current status of trial NCT01369758?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2010-11. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01369758?
The interventions under investigation include: MyoSure Tissue Removal System (DEVICE).
Who is sponsoring clinical trial NCT01369758?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.